Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biolase Inc (BIOL)

Biolase Inc (BIOL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025

NEW YORK , Nov. 25, 2025 /PRNewswire/ --  BIOLASE, the global leader in dental lasers, announced its participation in the 2025 Greater New York Dental Meeting (GNYDM) , taking place November...

BIOLQ : 0.0002 (+100.00%)
BIOL : 0.0174 (-71.98%)
Biolase: Q3 Earnings Snapshot

Biolase: Q3 Earnings Snapshot

BIOL : 0.0174 (-71.98%)
Biolase: Q2 Earnings Snapshot

Biolase: Q2 Earnings Snapshot

BIOL : 0.0174 (-71.98%)
Biolase: Q1 Earnings Snapshot

Biolase: Q1 Earnings Snapshot

BIOL : 0.0174 (-71.98%)
Biolase: Q4 Earnings Snapshot

Biolase: Q4 Earnings Snapshot

BIOL : 0.0174 (-71.98%)
Biolase: Q3 Earnings Snapshot

Biolase: Q3 Earnings Snapshot

BIOL : 0.0174 (-71.98%)
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants

/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously...

BIOL : 0.0174 (-71.98%)
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants

/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten...

BIOL : 0.0174 (-71.98%)
Biolase: Q2 Earnings Snapshot

Biolase: Q2 Earnings Snapshot

BIOL : 0.0174 (-71.98%)
BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR

/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30,...

BIOL : 0.0174 (-71.98%)

Barchart Exclusives

Spotify Just Raised U.S. Prices. How Should You Play SPOT Stock in January 2026?
With prices increasing, shares sliding, and leadership changing, is SPOT’s latest move a buying opportunity or a warning sign? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar